The DOI matches its Crossref record; 18 of the 18 references it cites were found in a registry or an index.
β-Amyloid-Induced Neuronal Apoptosis Involves c-Jun N-Terminal Kinase-Dependent Downregulation of Bcl-w
Open accessAbstract
β-Amyloid protein (Aβ) has been implicated as a key molecule in the neurodegenerative cascades of Alzheimer's disease (AD). Aβ directly induces neuronal apoptosis, suggesting an important role of Aβ neurotoxicity in AD neurodegeneration. However, the mechanism(s) of Aβ-induced neuronal apoptosis remain incompletely defined. In this study, we report that Aβ-induced neuronal death is preceded by selective alterations in expression of the Bcl-2 family of apoptosis-related genes. Specifically, we observe that Aβ significantly reduces expression of antiapoptotic Bcl-w and Bcl-xL, mildly affects expression of bim,Bcl-2, and bax, but does not alter expression of bak,bad,bik,bid, or BNIP3.Aβ-induced downregulation of Bcl-w appears to contribute to the mechanism of apoptosis, because Aβ-induced neuronal death was significantly increased by Bcl-w suppression but significantly reduced by Bcl-w overexpression. Downstream of Bcl-w, Aβ-induced neuronal apoptosis is characterized by mitochondrial release of second mitochondrion-derived activator of caspase (Smac), an important precursor event to cell death. We observed that Smac release was potentiated by suppression of Bcl-w and reduced by overexpression of Bcl-w. Next, we investigated the upstream mediator of Aβ-induced Bcl-w downregulation and Smac release. We observed that Aβ rapidly activates c-Jun N-terminal kinase (JNK). Pharmacological inhibition of JNK effectively inhibited all measures of Aβ apoptosis: Bcl-w downregulation, Smac release, and neuronal death. Together, these results suggest that the mechanism of Aβ-induced neuronal apoptosis sequentially involves JNK activation, Bcl-w downregulation, and release of mitochondrial Smac, followed by cell death. Complete elucidation of the mechanism of Aβ-induced apoptosis promises to accelerate development of neuroprotective interventions for the treatment of AD.
Overview
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
Inflammation and Alzheimer’s disease
Akiyama, H. (2000) · Neurobiology of Aging · doi:10.1016/s0197-4580(00)00124-x · Cited by 4,514
The Bcl2 family: regulators of the cellular life-or-death switch
Cory, S., & Adams, J. M. (2002) · Nature Reviews Cancer · doi:10.1038/nrc883 · Cited by 4,032 · cited 1×
“A key modulator of apoptosis pathways is the Bcl-2 family (Cory and Adams, 2002; Burlacu, 2003).”
BackgroundDiffusible, nonfibrillar ligands derived from Aβ 1–42 are potent central nervous system neurotoxins
Lambert, M. P., Barlow, A. K., Chromy, B. A., Edwards, C., Freed, R., Liosatos, M., Morgan, T. E., Rozovsky, I., Trommer, B., Viola, K. L., et al. (1998) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.95.11.6448 · Cited by 3,506 · cited 2×
“Although normally a soluble peptide (Haass et al., 1992; Shoji et al., 1992), A can assemble into a variety of oligomeric forms that are thought to underlie its pathogenic effects (Pike et al., 1993; Lambert et al., 1998; Hartley et al., 1999; Walsh et al., 1999; Hoshi et al., 2003).”
BackgroundDérijard, B., Hibi, M., Wu, I.-H., Barrett, T., Su, B., Deng, T., Karin, M., & Davis, R. J. (1994) · Cell · doi:10.1016/0092-8674(94)90380-8 · Cited by 3,188 · cited 1×
“JNK is a serine threonine protein kinase that phosphorylates c-Jun (Derijard et al., 1994; Kallunki et al., 1994), a component of the transcription factor-1 (AP-1) (Karin, 1995; Ip and Davis, 1998).”
BackgroundSP600125, an anthrapyrazolone inhibitor of Jun N-terminal kinase
Bennett, B. L., Sasaki, D. T., Murray, B. W., O'Leary, E. C., Sakata, S. T., Xu, W., Leisten, J. C., Motiwala, A., Pierce, S., Satoh, Y., et al. (2001) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.251194298 · Cited by 2,558 · cited 4×
“To begin exploring this idea, we investigated how A -induced Bcl-w downregulation is affected by SP600125, a specific inhibitor of JNK (Bennett et al., 2001).”
BackgroundMethodInfluentialAmyloid β-peptide is produced by cultured cells during normal metabolism
Haass, C., Schlossmacher, M. G., Hung, A. Y., Vigo-Pelfrey, C., Mellon, A., Ostaszewski, B. L., Lieberburg, I., Koo, E. H., Schenk, D., Teplow, D. B., et al. (1992) · Nature · doi:10.1038/359322a0 · Cited by 1,921 · cited 2×
“Although normally a soluble peptide (Haass et al., 1992; Shoji et al., 1992), A can assemble into a variety of oligomeric forms that are thought to underlie its pathogenic effects (Pike et al., 1993; Lambert et al., 1998; Hartley et al., 1999; Walsh et al., 1999; Hoshi et al., 2003).”
BackgroundProduction of the Alzheimer Amyloid β Protein by Normal Proteolytic Processing
Shoji, M., Golde, T. E., Ghiso, J., Cheung, T. T., Estus, S., Shaffer, L. M., Cai, X.-D., McKay, D. M., Tintner, R., Frangione, B., et al. (1992) · Science · doi:10.1126/science.1439760 · Cited by 1,447 · cited 1×
“…al., 1992; Ivins et al., 1998; Mattson et al., 1998) and neuronal death (Pike et al., 1991, 1993; Mattson et al., 1993; Lorenzo and Yankner, 1994; Simmons et al., 1994; Hartley et al., 1999; Hoshi et al., 2003) as well as to activate microglia (Meda et al., 1995; El Khoury et al., 1996) and…”
BackgroundNeurodegeneration induced by beta-amyloid peptides in vitro: the role of peptide assembly state
Pike, C., Burdick, D., Walencewicz, A., Glabe, C., & Cotman, C. (1993) · The Journal of Neuroscience · doi:10.1523/jneurosci.13-04-01676.1993 · Cited by 1,417
Self-citationAmyloid, the presenilins and Alzheimer’s disease
Hardy, J. (1997) · Trends in Neurosciences · doi:10.1016/s0166-2236(96)01030-2 · Cited by 1,370 · cited 1×
“Alzheimer’s disease (AD) is an age-related neurodegenerative disorder believed to be initiated by neural accumulation of -amyloid protein (A ) (Hardy, 1997; Selkoe, 2001).”
BackgroundBeta-amyloid neurotoxicity requires fibril formation and is inhibited by congo red.
Lorenzo, A., & Yankner, B. A. (1994) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.91.25.12243 · Cited by 1,324
Activation of microglial cells by β-amyloid protein and interferon-γ
Meda, L., Cassatella, M. A., Szendrei, G. I., Otvos, L., Baron, P., Villalba, M., Ferrari, D., & Rossi, F. (1995) · Nature · doi:10.1038/374647a0 · Cited by 1,314
Amyloid β-Protein Fibrillogenesis
Walsh, D. M., Hartley, D. M., Kusumoto, Y., Fezoui, Y., Condron, M. M., Lomakin, A., Benedek, G. B., Selkoe, D. J., & Teplow, D. B. (1999) · Journal of Biological Chemistry · doi:10.1074/jbc.274.36.25945 · Cited by 1,046 · cited 2×
“Although normally a soluble peptide (Haass et al., 1992; Shoji et al., 1992), A can assemble into a variety of oligomeric forms that are thought to underlie its pathogenic effects (Pike et al., 1993; Lambert et al., 1998; Hartley et al., 1999; Walsh et al., 1999; Hoshi et al., 2003).”
BackgroundScavenger receptor-mediated adhesion of microglia to β-amyloid fibrils
Khoury, J. E., Hickman, S. E., Thomas, C. A., Cao, L., Silverstein, S. C., & Loike, J. D. (1996) · Nature · doi:10.1038/382716a0 · Cited by 727 · cited 1×
“…et al., 1993; Lorenzo and Yankner, 1994; Simmons et al., 1994; Hartley et al., 1999; Hoshi et al., 2003) as well as to activate microglia (Meda et al., 1995; El Khoury et al., 1996) and astrocytes (Canning et al., 1993; Pike et al., 1994), which may indirectly injure neurons (Akiyama et al., 2000).”
BackgroundPike, C. J., Walencewicz‐Wasserman, A. J., Kosmoski, J., Cribbs, D. H., Glabe, C. G., & Cotman, C. W. (1995) · Journal of Neurochemistry · doi:10.1046/j.1471-4159.1995.64010253.x · Cited by 699 · cited 1×
“Before addition to cultures, A peptides were solubilized at 1 mM in sterile deionized water and were then incubated at 37°C for 1–3 d to yield peptide solutions in which A exhibits a range of assembly and conformation states, as described previously (Pike et al., 1993, 1995).”
MethodSelf-citationKallunki, T., Su, B., Tsigelny, I., Sluss, H. K., Dérijard, B., Moore, G., Davis, R., & Karin, M. (1994) · Genes & Development · doi:10.1101/gad.8.24.2996 · Cited by 642 · cited 1×
“JNK is a serine threonine protein kinase that phosphorylates c-Jun (Derijard et al., 1994; Kallunki et al., 1994), a component of the transcription factor-1 (AP-1) (Karin, 1995; Ip and Davis, 1998).”
BackgroundAmyloid-β Peptides Are Cytotoxic to Oligodendrocytes
Xu, J., Chen, S., Ahmed, S. H., Chen, H., Ku, G., Goldberg, M. P., & Hsu, C. Y. (2001) · The Journal of Neuroscience · doi:10.1523/jneurosci.21-01-j0001.2001 · Cited by 230 · cited 3×
“In complex with other DNA binding proteins, c-Jun/AP-1 regulates the transcription of numerous genes, suggesting the possibility that activated JNK-Jun/AP-1 pathway mediates A -induced Bcl-w downregulation.”
ResultIvins, K. J., Bui, E. T. N., & Cotman, C. W. (1998) · Neurobiology of Disease · doi:10.1006/nbdi.1998.0228 · Cited by 164 · cited 2×
“Oligomeric A is known to directly cause neurite damage (Pike et al., 1992; Ivins et al., 1998; Mattson et al., 1998) and neuronal death (Pike et al., 1991, 1993; Mattson et al., 1993; Lorenzo and Yankner, 1994; Simmons et al., 1994; Hartley et al., 1999; Hoshi et al., 2003) as well as to activate…”
Backgroundβ-Amyloid induces neuritic dystrophy in vitro: similarities with Alzheimer pathology
Pike, C. J., Cummings, B. J., & Cotman, C. W. (1992) · Neuroreport · doi:10.1097/00001756-199209000-00012 · Cited by 131 · cited 2×
“Oligomeric A is known to directly cause neurite damage (Pike et al., 1992; Ivins et al., 1998; Mattson et al., 1998) and neuronal death (Pike et al., 1991, 1993; Mattson et al., 1993; Lorenzo and Yankner, 1994; Simmons et al., 1994; Hartley et al., 1999; Hoshi et al., 2003) as well as to activate…”
BackgroundSelf-citation
Cited by
Mitochondrial membrane permeabilization in cell death
Kroemer, G., Galluzzi, L., & Brenner, C. (2007) · Physiological Reviews · doi:10.1152/physrev.00013.2006 · Cited by 3,598
Oxidative Stress and the Pathogenesis of Alzheimer's Disease
Zhao, Y., & Zhao, B. (2013) · Oxidative Medicine and Cellular Longevity · doi:10.1155/2013/316523 · Cited by 855
New insights into brain BDNF function in normal aging and Alzheimer disease
Tapia-Arancibia, L., Aliaga, E., Silhol, M., & Arancibia, S. (2008) · Brain Research Reviews · doi:10.1016/j.brainresrev.2008.07.007 · Cited by 571
Protective actions of sex steroid hormones in Alzheimer’s disease
Pike, C. J., Carroll, J. C., Rosario, E. R., & Barron, A. M. (2009) · Frontiers in Neuroendocrinology · doi:10.1016/j.yfrne.2009.04.015 · Cited by 522
Self-citationThe c-jun kinase/stress-activated pathway: Regulation, function and role in human disease
Johnson, G. L., & Nakamura, K. (2007) · Biochimica et Biophysica Acta (BBA) - Molecular Cell Research · doi:10.1016/j.bbamcr.2006.12.009 · Cited by 500
Metadata
- Authors
- Yao, M., Nguyen, T.-V. V., & Pike, C. J.
- Venue
- The Journal of Neuroscience
- Publisher
- Society for Neuroscience
- Published
- 2005-02-02
- Volume
- 25
- Issue
- 5
- Pages
- 1149-1158
- ISSN
- 0270-6474 (ISSN-L)
- 1529-2401
- OpenAlex
- W2030879023
- Cited by
- 231
- References
- 18
- FWCI
- 8.21
- Type
- journal article
- Language
- en
- Open access
- hybrid
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.